Over the past several years, Accelerate Diagnostics, together with our scientific collaborators, conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.
These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures.
Certain uses of devices included in these publications may not have been approved or cleared by the U.S. Food and Drug Administration or other regulatory bodies.
See product labeling for instructions for use, warnings, and limitations specific to each product and region.Okay, I understand. Show me the publications.
Evaluation of Rapid Antimicrobial Susceptibility Testing Methods for Gram-Negative Isolates
ASM Microbe 2019
Bhalodi A, Miquirray S, Perez I, Towne J, Humphries R (Accelerate Diagnostics)
One Step Closer to Enterobacteriaceae ID/AST Direct from Blood: Evaluating Pre-Process Incubation Times
ASM Microbe 2019
S. Giddins, I. Yushkevich, M. Fuchs, A. Irwin, S. Metzger, C. Price (Denver Health and Hospital Authority; Accelerate Diagnostics, Inc)
Improving Outcomes and Antibiotic Stewardship for Patients with Bacteremia (IOAS): An Interim Analysis of Gram-Negative Bacteremia (GNB) from the Accelerate PhenoTest™ BC Kit (AXDX) Registry Study
ASM Microbe 2019
S. H. MacVane, M. A. Ben-Aderet, J. Kolev, M. Madhusudhan, R. K. Dare, K. Lusardi, E. Rosenbaum, M. A. Morgan, R. M. Humphries (Accelerate Diagnostics, Inc., Cedars-Sinai Medical Center, University of Arkansas for Medical Sciences)
Making the Business Case for a Fast Diagnositic Platform for BSIs with a Clinical Implementation Support Team
Maureen Spencer, M.Ed, BSN, RN, CIC, FAPIC; Jared Sutton, MPH, CIC; Nicholas Strohminger, et al. (Accelerate Diagnostics, Inc.)
Clinical impact of rapid species identification from positive blood cultures with same-day phenotypic antimicrobial susceptibility testing on the management and outcome of bloodstream infections
Clinical Infectious Diseases
Ehren K, Meißner A, Jazmati N, et al. (University Hospital of Cologne)
A Pilot Study of Accelerate PhenoTest™ BC kit (AXDX) Compared to Standard Microbiological Testing on Blood Cultures Positive for Gram negative Bacilli
William Stokes MD, Lorraine Campbell, Johann Pitout MD, John Conly MD, Deirdre Church MD, Dan Gregson MD (University of Calgary, Calgary Laboratory Services)
Integration of a New Diagnostic Test with Antimicrobial Stewardship in a Community Hospital
Chirca I, Albrecht A, Patel A, et al. (University Hospital, University of Virginia)
Impact of Rapid Identification (ID) and Antimicrobial Susceptibility Testing (AST) on Antibiotic Therapy and Outcomes for Patients with Bacteraemia/Candidaemia
Sheth S, Miller M, Baker S (University of Maryland Eastern Shore, Peninsula Regional Medical Center)
Impact of rapid antimicrobial susceptibility test Accelerate Pheno™ in antimicrobial stewardship of sepsis
Belati A, De Socio G, Paggi R, et al. (University of Perugia, Perugia General Hospital)